Ochrobactrum anthropi Keratitis in a Boston Type 1 Keratoprosthesis Recipient

Cornea. 2021 May 1;40(5):662-663. doi: 10.1097/ICO.0000000000002571.

Abstract

Purpose: To report a case of Ochrobactrum anthropi keratitis in an eye with a Boston type 1 keratoprosthesis.

Methods: This is a case report and review of the literature.

Results: A 78-year-old man with a history of implantation of a Boston type 1 keratoprosthesis in the left eye presented for a routine follow-up with no acute complaints. In the left eye, visual acuity was 20/60 and slit-lamp examination revealed a 1.5-mm inferotemporal corneal infiltrate adjacent to the optic stem. Corneal cultures grew abundant O. anthropi. After 7 weeks of topical antimicrobial therapy and placement of a temporary tarsorrhaphy, the keratitis resolved.

Conclusions: Ochrobactrum anthropi is an organism associated with indwelling medical devices and can be pathogenic in eyes with implanted keratoprostheses.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Artificial Organs*
  • Ceftazidime / therapeutic use
  • Cornea*
  • Corneal Ulcer / diagnosis*
  • Corneal Ulcer / drug therapy
  • Corneal Ulcer / microbiology
  • Drug Therapy, Combination
  • Eye Infections, Bacterial / diagnosis*
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / microbiology
  • Gram-Negative Bacterial Infections / diagnosis*
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Male
  • Moxifloxacin / therapeutic use
  • Ochrobactrum anthropi / isolation & purification*
  • Prostheses and Implants*
  • Slit Lamp Microscopy
  • Visual Acuity

Substances

  • Anti-Bacterial Agents
  • Ceftazidime
  • Moxifloxacin